L
LSPL
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C | 6 | 7.1 | 4.7 | 9.4 | 6 Nov 2025 |
| Tirzepatide | C | 14 | 7.1 | 4.5 | 10.0 | 11 Jun 2025 |
| Retatrutide | E | 20 | 6.4 | 1.6 | 10.0 | 6 Nov 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | C | 2 | 6.3 | 5.0 | 7.7 | 23 May 2026 |
| 5-amino-1MQ | X | 1 | 6.1 | 6.1 | 6.1 | 7 May 2025 |
| AA Water | C | 3 | 5.4 | 3.7 | 7.0 | 19 Jan 2026 |
| BAM15 | X | 1 | 9.0 | 9.0 | 9.0 | 11 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | C | 4 | 5.8 | 5.2 | 6.6 | 24 May 2026 |
| BPC157 5mg + TB500 5mg Blend | C | 2 | 5.6 | 5.4 | 5.8 | 21 May 2026 |
| Cabergoline | X | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | C | 3 | 6.9 | 4.2 | 9.8 | 26 Jan 2026 |
| CJC-1295 With DAC | C | 3 | 6.1 | 4.0 | 9.2 | 20 May 2026 |
| Clenbuterol | X | 1 | 4.0 | 3.9 | 3.9 | 6 May 2025 |
| Dianabol Raw | C | 3 | 6.7 | 5.9 | 7.7 | 21 May 2026 |
| Dihexa | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| EPO | C | 3 | 8.1 | 6.7 | 9.4 | 24 May 2026 |
| Equipoise (Boldenone Undecylenate) | C | 3 | 5.9 | 3.5 | 7.4 | 20 May 2026 |
| GHRP-2 Acetate | X | 1 | 8.8 | 8.8 | 8.8 | 24 Apr 2025 |
| GHRP-6 Acetate | C | 4 | 7.8 | 6.5 | 8.7 | 17 May 2026 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | C | 3 | 5.7 | 4.7 | 6.7 | 23 May 2026 |
| HCG | C | 3 | 7.1 | 5.9 | 9.1 | 26 Jan 2026 |
| Hyaluronic acid | C | 4 | 6.0 | 2.7 | 7.9 | 21 May 2026 |
| IGF-1 LR3 | C | 2 | 6.9 | 5.5 | 8.3 | 21 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | C | 2 | 8.1 | 7.6 | 8.6 | 26 Jan 2026 |
| Letrozole | C | 4 | 5.1 | 3.6 | 6.7 | 24 May 2026 |
| LGD-4033 (Ligandrol) | C | 2 | 5.5 | 5.5 | 5.6 | 21 May 2026 |
| Nitroethane CAS 79-24-3 | X | 1 | 5.7 | 5.7 | 5.7 | 7 May 2025 |
| Ovagen | C | 3 | 6.3 | 5.3 | 7.2 | 24 May 2026 |
| P21 | C | 2 | 6.0 | 5.6 | 6.5 | 23 May 2026 |
| PEG MGF | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| PNC 27 | C | 3 | 7.5 | 7.0 | 7.9 | 24 May 2026 |
| Retatrutide 30mg Pen Kit | X | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 |
| Romosozumab | C | 3 | 7.4 | 6.6 | 8.5 | 20 May 2026 |
| Selank 10mg + Semax 10mg Blend | C | 3 | 5.2 | 4.2 | 6.4 | 23 May 2026 |
| Semaglutide Raw | X | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| Semax | C | 4 | 5.8 | 4.4 | 6.7 | 17 May 2026 |
| SNAP-8 | C | 2 | 6.5 | 5.9 | 7.0 | 21 May 2026 |
| SS-31 | C | 4 | 6.0 | 3.8 | 7.7 | 20 May 2026 |
| Tesofensine | C | 3 | 7.5 | 6.9 | 8.0 | 25 May 2026 |
| Test Propionate | C | 4 | 7.2 | 6.2 | 8.8 | 23 May 2026 |
| Trenbolone Enanthate | C | 4 | 5.8 | 4.6 | 6.9 | 24 May 2026 |
| YK11 | C | 3 | 6.7 | 5.7 | 8.7 | 26 Jan 2026 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Nitroethane CAS 79-24-3 | 5.7 | 10g | 10.1g | +0.8% | 97.81% | Lab A |
| 25 May 2026 | YK11 | 6.1 | 25mg | 24.0mg | -3.8% | 95.04% | Lab F |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 6.9 | 1g | 1.2g | +15.1% | 96.70% | Lab E |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.9 | 5mg | 5.1mg | +2.5% | 97.88% | Lab G |
| 24 May 2026 | Dianabol Raw | 7.4 | 10g | 12.5g | +24.5% | 96.51% | Lab C |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 7.9 | 200mg/ml | 181.6mg/ml | -9.2% | 98.63% | Lab C |
| 24 May 2026 | AA Water | 5.2 | 5mg | 5.6mg | +11.7% | 97.80% | Lab G |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 5.1 | 2mg | 2.4mg | +20.9% | 97.93% | Lab E |
| 24 May 2026 | Tesofensine | 8.0 | 20mg | 19.9mg | -0.5% | 99.93% | Lab E |
| 24 May 2026 | Test Propionate | 9.2 | 100mg/ml | 107.5mg/ml | +7.5% | 99.10% | Lab E |
| 24 May 2026 | LGD-4033 (Ligandrol) | 4.0 | 10mg | 9.9mg | -0.9% | 97.09% | Lab C |
| 24 May 2026 | SNAP-8 | 7.6 | 15mg | 13.5mg | -10.0% | 95.36% | Lab C |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 4.3 | 5g | 6.1g | +21.4% | 96.10% | Lab A |
| 24 May 2026 | CJC-1295 With DAC | 5.6 | 2mg | 1.9mg | -5.7% | 99.50% | Lab C |
| 24 May 2026 | Romosozumab | 10.0 | 30mg | 35.1mg | +17.1% | 96.39% | Lab E |
| 24 May 2026 | SS-31 | 5.1 | 30mg | 30.5mg | +1.7% | 99.51% | Lab F |
| 24 May 2026 | SNAP-8 | 4.4 | 10mg | 12.5mg | +24.9% | 96.73% | Lab C |
| 24 May 2026 | Trenbolone Enanthate | 6.7 | 100mg/ml | 115.7mg/ml | +15.7% | 99.72% | Lab C |
| 23 May 2026 | Letrozole | 4.9 | 50mg | 61.1mg | +22.2% | 96.44% | Lab F |
| 23 May 2026 | Ovagen | 5.3 | 5mg | 4.6mg | -7.6% | 96.60% | Lab C |
| 23 May 2026 | Retatrutide 30mg Pen Kit | 6.1 | 5mg | 4.7mg | -5.3% | 97.42% | Lab E |
| 23 May 2026 | 5-amino-1MQ | 7.8 | 30mg | 32.1mg | +6.9% | 98.36% | Lab B |
| 23 May 2026 | Hyaluronic acid | 5.7 | 50mg | 47.2mg | -5.6% | 97.77% | Lab G |
| 22 May 2026 | GHK-Cu | 4.9 | 50mg | 62.4mg | +24.8% | 99.90% | Lab E |
| 21 May 2026 | Tirzepatide | 5.2 | 10mg | 8.25mg | -17.5% | 99.87% | Lab E |
| 21 May 2026 | Retatrutide | 4.4 | 10mg | 17.1mg | +71.0% | 99.90% | Lab E |
| 21 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 6.5 | 2mg | 2.3mg | +14.9% | 99.91% | Lab E |
| 21 May 2026 | Tirzepatide | 6.0 | 10mg | 10.7mg | +7.0% | 99.32% | Lab E |
| 21 May 2026 | GHK-Cu | 7.8 | 50mg | 47.2mg | -5.6% | 99.90% | Lab E |
| 21 May 2026 | Hyaluronic acid | 4.7 | 50mg | 55.9mg | +11.9% | 99.06% | Lab E |
| 21 May 2026 | Letrozole | 6.2 | 20mg | 19.1mg | -4.7% | 95.22% | Lab A |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 6.6 | 50mg | 59.4mg | +18.8% | 95.83% | Lab B |
| 20 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.5 | 2mg | 2.2mg | +12.1% | 99.93% | Lab A |
| 19 May 2026 | GHRP-6 Acetate | 7.5 | 15mg | 16.2mg | +8.1% | 98.16% | Lab B |
| 19 May 2026 | Ovagen | 7.3 | 10mg | 12.1mg | +20.7% | 96.89% | Lab E |
| 19 May 2026 | YK11 | 6.4 | 50mg | 45.0mg | -10.0% | 95.89% | Lab B |
| 17 May 2026 | Dihexa | 8.2 | 100mg | 93.9mg | -6.1% | 95.18% | Lab G |
| 17 May 2026 | GHRP-6 Acetate | 4.8 | 10mg | 11.6mg | +15.6% | 97.08% | Lab E |
| 17 May 2026 | PEG MGF | 6.0 | 15mg | 13.6mg | -9.6% | 96.80% | Lab B |
| 29 Jan 2026 | Retatrutide | 4.5 | 10mg | 6.01mg | -39.9% | 98.72% | Lab E |
| 29 Jan 2026 | Retatrutide | 9.2 | 20mg | 19.1mg | -4.5% | 99.59% | Lab E |
| 29 Jan 2026 | PNC 27 | 8.2 | 20mg | 24.6mg | +22.8% | 97.24% | Lab A |
| 26 Jan 2026 | AA Water | 6.0 | 15mg | 18.2mg | +21.7% | 95.13% | Lab A |
| 26 Jan 2026 | Cabergoline | 8.3 | 25mg | 29.0mg | +16.0% | 97.40% | Lab A |
| 26 Jan 2026 | Dianabol Raw | 6.3 | 500g | 618.8g | +23.8% | 97.63% | Lab B |
| 26 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 7.8 | 50mg | 43.6mg | -12.8% | 99.07% | Lab D |
| 26 Jan 2026 | SS-31 | 4.5 | 15mg | 14.4mg | -3.8% | 95.52% | Lab F |
| 19 Jan 2026 | AA Water | 5.3 | 20mg | 17.8mg | -11.1% | 98.47% | Lab E |
| 19 Jan 2026 | Equipoise (Boldenone Undecylenate) | 6.2 | 200mg/ml | 227.8mg/ml | +13.9% | 98.96% | Lab D |
| 9 Jan 2026 | HCG | 6.3 | 15mg | 15.7mg | +4.5% | 97.26% | Lab G |
| 9 Jan 2026 | Ovagen | 4.6 | 50mg | 54.1mg | +8.2% | 95.73% | Lab B |
| 9 Jan 2026 | Selank 10mg + Semax 10mg Blend | 6.2 | 2mg | 2.3mg | +13.3% | 99.75% | Lab G |
| 9 Jan 2026 | Semaglutide Raw | 4.9 | 100g | 105.9g | +5.9% | 99.25% | Lab G |
| 9 Jan 2026 | Semax | 5.0 | 2mg | 1.8mg | -11.1% | 95.91% | Lab D |
| 7 Jan 2026 | YK11 | 7.6 | 20mg | 24.6mg | +23.2% | 96.03% | Lab F |
| 6 Jan 2026 | HCG | 7.8 | 2mg | 2.5mg | +24.1% | 97.19% | Lab E |
| 6 Jan 2026 | Hyaluronic acid | 5.2 | 5mg | 5.8mg | +16.1% | 95.74% | Lab F |
| 6 Jan 2026 | Trenbolone Enanthate | 7.1 | 300mg/ml | 339.1mg/ml | +13.0% | 95.26% | Lab A |
| 29 Dec 2025 | BAM15 | 9.5 | 50mg | 55.6mg | +11.3% | 96.96% | Lab E |
| 29 Dec 2025 | BPC157 10mg + TB500 10mg Blend | 4.7 | 2mg | 2.5mg | +24.6% | 95.53% | Lab E |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.0 | 20mg | 24.0mg | +19.8% | 98.21% | Lab B |
| 29 Dec 2025 | CJC-1295 With DAC | 6.6 | 15mg | 17.5mg | +16.3% | 95.92% | Lab B |
| 29 Dec 2025 | Dianabol Raw | 4.3 | 10g | 9.9g | -1.0% | 95.32% | Lab C |
| 29 Dec 2025 | GHRP-2 Acetate | 7.3 | 30mg | 25.7mg | -14.4% | 97.31% | Lab C |
| 29 Dec 2025 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 6.1 | 30mg | 29.8mg | -0.5% | 97.22% | Lab D |
| 29 Dec 2025 | Letrozole | 5.4 | 100mg | 115.0mg | +15.0% | 99.74% | Lab D |
| 29 Dec 2025 | Tesofensine | 7.8 | 10mg | 11.6mg | +15.8% | 97.83% | Lab G |
| 29 Dec 2025 | Test Propionate | 5.8 | 100mg/ml | 89.9mg/ml | -10.1% | 99.68% | Lab F |
| 12 Dec 2025 | Selank 10mg + Semax 10mg Blend | 5.1 | 10mg | 11.0mg | +10.1% | 97.32% | Lab E |
| 5 Dec 2025 | Equipoise (Boldenone Undecylenate) | 6.1 | 200mg/ml | 246.5mg/ml | +23.2% | 99.67% | Lab G |
| 5 Dec 2025 | HCG | 8.5 | 2mg | 2.3mg | +17.1% | 97.25% | Lab C |
| 5 Dec 2025 | Semax | 7.0 | 5mg | 6.2mg | +23.6% | 99.85% | Lab D |
| 23 Nov 2025 | CJC-1295 With DAC | 4.1 | 30mg | 29.5mg | -1.5% | 97.78% | Lab D |
| 23 Nov 2025 | Clenbuterol | 4.0 | 20mg | 20.3mg | +1.3% | 95.25% | Lab A |
| 23 Nov 2025 | EPO | 8.1 | 50mg | 44.4mg | -11.2% | 97.07% | Lab C |
| 23 Nov 2025 | Romosozumab | 6.8 | 50mg | 46.6mg | -6.8% | 98.48% | Lab C |
| 17 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 4.3 | 10mg | 10.6mg | +6.3% | 97.42% | Lab B |
| 17 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.5 | 50mg | 58.7mg | +17.3% | 99.76% | Lab C |
| 17 Nov 2025 | LGD-4033 (Ligandrol) | 5.3 | 10mg | 11.9mg | +18.6% | 96.42% | Lab B |
| 17 Nov 2025 | PNC 27 | 8.2 | 15mg | 14.7mg | -1.8% | 95.71% | Lab B |
| 17 Nov 2025 | PNC 27 | 5.9 | 10mg | 9.7mg | -2.7% | 95.29% | Lab F |
| 17 Nov 2025 | Semax | 5.6 | 10mg | 9.1mg | -9.4% | 99.87% | Lab D |
| 14 Nov 2025 | IGF-1 LR3 | 6.7 | 15mg | 13.1mg | -12.8% | 96.16% | Lab A |
| 14 Nov 2025 | P21 | 5.2 | 20mg | 20.6mg | +2.9% | 98.07% | Lab E |
| 14 Nov 2025 | Test Propionate | 6.9 | 300mg/ml | 337.6mg/ml | +12.5% | 97.11% | Lab F |
| 4 Nov 2025 | Hyaluronic acid | 7.7 | 30mg | 35.4mg | +17.9% | 97.14% | Lab G |
| 4 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.0 | 2mg | 2.0mg | -2.3% | 97.79% | Lab C |
| 4 Nov 2025 | P21 | 7.5 | 50mg | 55.9mg | +11.9% | 95.16% | Lab A |
| 4 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.8 | 15mg | 17.4mg | +15.7% | 96.24% | Lab E |
| 4 Nov 2025 | SS-31 | 5.7 | 2mg | 2.4mg | +19.8% | 98.84% | Lab A |
| 4 Nov 2025 | Tesofensine | 9.5 | 100mg | 86.9mg | -13.1% | 99.35% | Lab D |
| 4 Nov 2025 | Trenbolone Enanthate | 4.0 | 200mg/ml | 188.2mg/ml | -5.9% | 98.05% | Lab F |
| 17 Oct 2025 | EPO | 8.8 | 20mg | 18.9mg | -5.4% | 95.79% | Lab D |
| 17 Oct 2025 | Romosozumab | 9.0 | 50mg | 60.7mg | +21.3% | 98.23% | Lab G |
| 17 Oct 2025 | Semax | 6.0 | 15mg | 13.6mg | -9.1% | 98.35% | Lab C |
| 17 Oct 2025 | Test Propionate | 8.4 | 300mg/ml | 320.0mg/ml | +6.7% | 97.95% | Lab G |
| 9 Oct 2025 | BPC157 10mg + TB500 10mg Blend | 5.8 | 50mg | 54.5mg | +8.9% | 97.31% | Lab F |
| 9 Oct 2025 | IGF-1 LR3 | 6.9 | 30mg | 31.1mg | +3.7% | 95.82% | Lab A |
| 9 Oct 2025 | Letrozole | 5.0 | 50mg | 42.8mg | -14.5% | 99.73% | Lab A |
| 9 Oct 2025 | SS-31 | 5.1 | 20mg | 23.3mg | +16.5% | 99.94% | Lab B |
| 9 Oct 2025 | Trenbolone Enanthate | 7.0 | 300mg/ml | 278.6mg/ml | -7.1% | 95.36% | Lab C |
| 3 Oct 2025 | BPC157 10mg + TB500 10mg Blend | 6.0 | 15mg | 13.0mg | -13.6% | 96.47% | Lab A |
| 3 Oct 2025 | EPO | 10.0 | 10mg | 10.6mg | +6.4% | 96.46% | Lab E |
| 3 Oct 2025 | GHRP-6 Acetate | 8.4 | 10mg | 11.1mg | +11.2% | 98.30% | Lab B |
| 3 Oct 2025 | GHRP-6 Acetate | 9.0 | 15mg | 13.7mg | -8.6% | 96.03% | Lab A |